The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level

Kamel N., Compton C., Middelveld R., Higenbottam T., Dahlen S-E.

Source: Eur Respir J 2008; 31: 924-926
Journal Issue: May

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kamel N., Compton C., Middelveld R., Higenbottam T., Dahlen S-E.. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level. Eur Respir J 2008; 31: 924-926

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Health Research collaboration in Europe: an innovative initiative
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013


The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients
Source:
Year: 2008


Better Medicines for Children - European regulation, European research networks, Funding opportunities
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006

The ERS European Forum for TB Innovation in Europe: a new way to raise innovation
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013



The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP)
Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016
Year: 2017



The Alliance for biomedical research in Europe
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014

How to assist bringing new drugs to patients: role of the European Medicines Agency
Source: International Congress 2019 – Rare lung diseases
Year: 2019


Biomedical research in the EU
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011


Medicines for children in Europe: from proposals to practicalities
Source: Eur Respir J 2010; 35: 228-229
Year: 2010


European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?
Source: Eur Respir J 2016; 48: 1564-1568
Year: 2016


Policy implementation for the ban of characterising flavours in tobacco products in the European Union: The EUREST-FLAVOURS Project
Source: International Congress 2019 – From the epidemiology of tobacco/electronic nicotine delivery system use to control and prevention of tobacco use
Year: 2019

Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017



Biomedical research by industry
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011


Italian Presidency of the EU: health priorities
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014

Innovative Medicines Initiatives (IMI)
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


ERS Clinical Research Collaborations: underpinning research excellence
Source: Eur Respir J, 52 (3) 1801534; 10.1183/13993003.01534-2018
Year: 2018



Doing Science: managing colleagues and collaborations in scientific research
Source: Breathe 2015; 11:77-79
Year: 2015